ALKEUS PHARMACEUTICALS INC
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated . These are the last published financial totals; newer source data is not included yet.
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under ALKEUS PHARMACEUTICALS INC.
Showing the last published contribution snapshot. Newer source data is not included yet.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Alkeus Pharmaceuticals, Inc.. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–2 of 2 · largest absolute amount first
Evidence-based cluster of 3 reported identities; not a verified identity merge · BOSTON, MA, 02210 · ALKEUS PHARMACEUTICALS. · Healthcare & Pharmaceuticals · BIOTECH EXECUTIVE · Reported as BOGER, JOSHUA / BOGER, JOSHUA S. / BOGER, JOSHUA S · 30 transaction rows
Reported name + ZIP cluster; not a verified identity merge · ACTON, MA, 01720 · ALKEUS PHARMACEUTICALS · Healthcare & Pharmaceuticals · SCIENTIST · 2 transaction rows
Where the contributions went · 10 per page
Showing 1–10 of 18 · largest absolute amount first
Hybrid PAC (qualified) · WASHINGTON, DC · 1 transaction rows
PAC (not qualified) · RALEIGH, NC · 2 transaction rows
Senate campaign committee · DENVER, CO · HICKENLOOPER, JOHN W. · U.S. Senate CO 00 · 3 transaction rows
House campaign committee · WASHINGTON, DC · CLARK, KATHERINE · U.S. House MA 05 · 3 transaction rows
Party committee (qualified) · BOSTON, MA · 2 transaction rows
Senate campaign committee · RALEIGH, NC · COOPER, ROY · U.S. Senate NC 00 · 2 transaction rows
Senate campaign committee · WILLIAMSBURG, VA · WARNER, MARK ROBERT · U.S. Senate VA 00 · 2 transaction rows
PAC (not qualified) · WILLIAMSBURG, VA · 2 transaction rows
House campaign committee · WILMINGTON, DE · MCBRIDE, SARAH ELIZABETH · U.S. House DE 00 · 2 transaction rows
Senate campaign committee · PORTLAND, ME · MILLS, JANET TRAFTON · U.S. Senate ME 00 · 2 transaction rows
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Showing the last published contribution records; newer source data is not included yet.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2026-04-14FEC filing ↗ | $50,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS. | LEADERS WE DESERVEC00843110Primary (P)NON-CONTRIBUTION ACCOUNTFiling 1979595 · amended |
| 2025-08-07FEC filing ↗ | $17,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR COOPER VICTORY FUND (C00913574)Filing 1953256 · amended |
| 2025-08-07FEC filing ↗ | $17,000 | BOGER, JOSHUABOSTONMA02210EXECUTIVEALKEUS PHARMACEUTICALS | COOPER VICTORY FUNDC00913574Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE ON 08/10/2025Filing 1956706 · amended |
| 2025-06-17FEC filing ↗ | $7,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR HICKENLOOPER FOR COLORADO (C00716720)Filing 1909062 |
| 2025-02-04FEC filing ↗ | $6,600 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR KATHERINE CLARK FOR CONGRESS (C00541888)Filing 1909062 |
| 2025-04-26FEC filing ↗ | $5,000 | BOGER, JOSHUA SBOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | MASSACHUSETTS DEMOCRATIC STATE COMMITTEE - FED FUNDC00089243Primary (P)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1893597 |
| 2025-04-26FEC filing ↗ | $5,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR MASSACHUSETTS DEMOCRATIC STATE COMMITTEE - FEDERAL ACCOUNT (C00089243)Filing 1909062 |
| 2025-02-20FEC filing ↗ | $5,000 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR HICKENLOOPER FOR COLORADO (C00716720)Filing 1909062 |
| 2025-12-11FEC filing ↗ | $3,500 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR MILLS FOR MAINE (C00923144)Filing 1953256 · amended |
| 2025-08-09FEC filing ↗ | $3,500 | BOGER, JOSHUABOSTONMA02210BIOTECH EXECUTIVEALKEUS PHARMACEUTICALS | ACTBLUEC00401224Not reportedEARMARKED FOR MCBRIDE FOR DELAWARE (C00843763)Filing 1953256 · amended |
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Reported as ALKEUS PHARMACEUTICALS INC
Industry classification summary
Alkeus Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for retinal diseases, as documented in its official about page and clinical news releases.
AI-generated classification based on saved sources
View source